Research News
Study Finds Many Ovarian Cancer Patients Going Untreated
(July 6, 2016) Gynecologic Oncology recently published a study that found that, although surgery leads to longer survival rates, many ovarian cancer patients are not undergoing surgery, and some are not being treated at all…
Listen Now: Research Updates from 2016’s Top Medical Meetings
Every year cancer researchers and doctors gather at several professional meetings to present and discuss the latest and most important advances in basic, translational and clinical cancer research…
The Effect of Oral Contraceptives on Ovarian Cancer
(June 23, 2016) The Journal of Clinical Oncology recently published a study on the role of oral contraceptives (OC) on ovarian cancer prevention…
June 2016 ASCO Highlights
Highlights from the June 2016 American Society of Clinical Oncology (ASCO) Annual Meeting by Susan Leighton, Ovarian Cancer Survivor and Research Advocate Since the first time I attended ASCO I have seen the number of abstracts presented about…
Highlights from the June 2016 American Society of Clinical Oncology (ASCO) Annual Meeting
(June 20, 2016) Highlights from the June 2016 American Society of Clinical Oncology (ASCO) Annual Meeting by Susan Leighton, Ovarian Cancer Survivor and Research Advocate Since the first time I attended ASCO I have seen the number of…
OCRFA Research Sheds Light on Role of STAT3 in Ovarian Cancer
(June 17, 2016) An OCRFA funded study recently published in Oncogene investigated the role that protein STAT3 plays in the activation and metastasis of ovarian cancer cells…
OCRFA Research Shows Genetic Subtypes Linked to Increased Risk of Ovarian Cancer
(June 9, 2016) A ten year, OCRFA-funded study has revealed the effect that the human leukocyte antigen (HLA) genes, which help regulate the body’s immune system, have on how the body responds to treatment of epithelial ovarian cancer…
Risk Factors and Outcomes for Chemotherapy Refusal
(June 7, 2016) The Journal of the National Comprehensive Cancer Network recently published a study that looked at the difference in outcomes between two groups of epithelial ovarian cancer patients: those who received recommended, multiagent…
The Impact of BMI on IP Therapy
(May 25, 2016) A new study published in the International Journal of Gynecological Cancer earlier this month investigated the impact of body mass index (BMI) on completion, complications, and clinical outcomes of intraperitoneal (IP) chemotherapy in…
Webinar: Clinical Trials: What you need to know
Oliver Dorigo, MD, PhD, Director of the Stanford Gynecologic Oncology Clinical Care Program and Director of Stanford Obstetrics and Gynecology’s Division of Gynecologic Oncology provided an introduction to clinical trials for ovarian cancer…
Long Term Survival Study Recruiting Participants
The Consortium for Long-Term Survival — is bringing together research groups worldwide…
OCRFA Research Helps Explain Resistance to Chemotherapy
(May 4, 2016) Research funded in part by an OCRFA research grant to Dr…